reference/1306753

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1306753

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2095
issn	1096-9071 0146-6615
issueIdentifier	10
pageRange	2087-2095
publicationName	Journal of Medical Virology
startingPage	2087
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a998e811f01067fe4c6518f9e6dff2e3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ac91e3e48cdb2a6ec8e421ebd449241b
bibliographicCitation	Musarrat F, Chouljenko V, Dahal A, Nabi R, Chouljenko T, Jois SD, Kousoulas KG. The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections. Journal of Medical Virology. 2020 May 17;92(10):2087–95. doi: 10.1002/jmv.25985.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcca673927b003963ccb655ae445964f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cf8d2e3815b388cc7f682900684b984 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10b0b7a9e7dbacbbc4d7c50ae4c2a6cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cb3873fcdcac4b09cc9e22a21e5ddaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5d9ca4c8cc7020e054b7ed43102c096 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46f17cd852bd5c0606f9dd8a8a0df815 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7077-9003
date	2020-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32374457 https://doi.org/10.1002/jmv.25985 https://pubmed.ncbi.nlm.nih.gov/PMC7267418
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4750 https://portal.issn.org/resource/ISSN/1096-9071 https://portal.issn.org/resource/ISSN/0146-6615
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections
discusses	http://id.nlm.nih.gov/mesh/M0488749 http://id.nlm.nih.gov/mesh/M000683757 http://id.nlm.nih.gov/mesh/M0029531 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0581462 http://id.nlm.nih.gov/mesh/M0028839
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D064370Q000037 http://id.nlm.nih.gov/mesh/D045473Q000187 http://id.nlm.nih.gov/mesh/D008561Q000187 http://id.nlm.nih.gov/mesh/D019380Q000494 http://id.nlm.nih.gov/mesh/D000086402Q000187 http://id.nlm.nih.gov/mesh/D019888Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D064370Q000235 http://id.nlm.nih.gov/mesh/D015726Q000187 http://id.nlm.nih.gov/mesh/D010957Q000378 http://id.nlm.nih.gov/mesh/D054730 http://id.nlm.nih.gov/mesh/D045473Q000502 http://id.nlm.nih.gov/mesh/D062105 http://id.nlm.nih.gov/mesh/D010957Q000737 http://id.nlm.nih.gov/mesh/D015726Q000473 http://id.nlm.nih.gov/mesh/D014709 http://id.nlm.nih.gov/mesh/D001665 http://id.nlm.nih.gov/mesh/D000086402Q000472 http://id.nlm.nih.gov/mesh/D015726Q000821 http://id.nlm.nih.gov/mesh/D019380Q000737 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019888Q000737 http://id.nlm.nih.gov/mesh/D045473Q000472 http://id.nlm.nih.gov/mesh/D000093485 http://id.nlm.nih.gov/mesh/D011994Q000378 http://id.nlm.nih.gov/mesh/D011994Q000235 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D011994Q000737 http://id.nlm.nih.gov/mesh/D014771Q000502 http://id.nlm.nih.gov/mesh/D014771Q000472 http://id.nlm.nih.gov/mesh/D002459 http://id.nlm.nih.gov/mesh/D014771Q000187 http://id.nlm.nih.gov/mesh/D000086402Q000502 http://id.nlm.nih.gov/mesh/D011485 http://id.nlm.nih.gov/mesh/D064370Q000737 http://id.nlm.nih.gov/mesh/D002522 http://id.nlm.nih.gov/mesh/D064370Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64143 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64142 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10809 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637579

Total number of triples: 80.